Purchase Order 36C26325P0795

Award Date 5/20/25
Potential Completion Date 5/21/25
Potential Value $34K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Minneapolis, MN 55417, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $34,000, was issued by the U.S. Department of Veterans Affairs (VA) to Edwards Lifesciences LLC, a for-profit limited liability company and subsidiary of Edwards Lifesciences Corporation. The contract is for the provision of TAVR (Transcatheter Aortic Valve Replacement) products and is structured as a firm fixed-price purchase order. It has an ultimate completion date of June 20, 2025. Edwards Lifesciences LLC is a global leader in medical innovations for...
The U.S. Department of Veterans Affairs (VA) awarded a firm fixed-price purchase order contract valued at $34,000.00 to Edwards Lifesciences LLC, a for-profit limited liability company and subsidiary of Edwards Lifesciences Corporation. The contract is for the delivery of Transcatheter Aortic Valve Replacement (TAVR) products, which are specialized cardiovascular medical devices used to enhance surgical and cardiovascular care for veterans. This award is part of a larger Indefinite Delivery...
This federal contract award, with ID 36C26325P0730, was made by the U.S. Department of Veterans Affairs (VA) to Edwards Lifesciences LLC, a for-profit limited liability company and subsidiary of Edwards Lifesciences Corporation. The contract is for the delivery of Transcatheter Aortic Valve Replacement (TAVR) products, with a firm fixed price of $34,000.00 and a performance period through May 28, 2025. Edwards Lifesciences LLC holds a significant Indefinite Delivery Contract (IDC) valued at...
This federal contract award is for the purchase of transcatheter aortic valve replacement (TAVR) products from Edwards Lifesciences LLC, a for-profit limited liability company and subsidiary of Edwards Lifesciences Corporation. The $34,000 firm fixed-price contract was awarded by the U.S. Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 23. The contract has an ultimate completion date of May 16, 2025 and does not utilize a set-aside designation. Edwards...
This federal contract award, identified as 36C26325P0791, was issued by the U.S. Department of Veterans Affairs (VA) to Edwards Lifesciences LLC, a for-profit limited liability company and a subsidiary of Edwards Lifesciences Corporation. The contract, valued at $32,500.00, is for the provision of Transcatheter Aortic Valve Replacement (TAVR) products and related cardiovascular medical devices. The contract is a firm fixed-price purchase order with a performance period through May 20, 2025....
This federal contract award, valued at $34,000.00, was issued by the U.S. Department of Veterans Affairs (VA) to Edwards Lifesciences LLC, a for-profit limited liability company and subsidiary of Edwards Lifesciences Corporation. The contract is for the provision of PROSTHETICS. TAVR KIT., which are specialized cardiovascular medical devices used in transcatheter aortic valve replacement (TAVR) procedures. Edwards Lifesciences LLC is a global leader in medical innovations for structural heart...
This federal contract award to Edwards Lifesciences LLC, a for-profit limited liability company and small disadvantaged business, is for the provision of transcatheter aortic valve replacement (TAVR) products and services. The $34,000 firm fixed-price purchase order was awarded by the U.S. Department of Veterans Affairs and Veterans Health Administration, specifically the Veterans Integrated Service Network 23, to support cardiovascular care for veterans. The contract has an ultimate...
This is a federal contract award to Edwards Lifesciences LLC, a for-profit limited liability company and small disadvantaged business, by the U.S. Department of Veterans Affairs (VA) and Veterans Health Administration (VHA). The contract, valued at $34,000.00, is for the provision of transcatheter aortic valve replacement (TAVR) products and services. The contract has a firm fixed price pricing type and a period of performance through October 17, 2024. Edwards Lifesciences LLC has received...
The U.S. Department of Veterans Affairs (VA) awarded a $45,000.00 firm fixed price purchase order contract to Edwards Lifesciences LLC, a for-profit limited liability company, for the delivery of prosthetic transcatheter aortic valve replacement (TAVR) devices. The contract has an ultimate completion date of February 22, 2025. Edwards Lifesciences LLC is a small disadvantaged business that has received numerous prime contract awards from the VA and Veterans Health Administration (VHA) to provide...
This federal contract was awarded by the U.S. Department of Veterans Affairs (VA) to Edwards Lifesciences LLC, a for-profit limited liability company and subsidiary of Edwards Lifesciences Corporation. The $34,000 firm fixed-price purchase order is for the delivery of heart valves to support the VA's Veterans Health Administration (VHA). The contract has an ultimate completion date of July 10, 2025 and was awarded on April 11, 2025. This award is part of a larger $1,190,000 Indefinite Delivery...

This federal contract award, valued at $34,000.00, was issued by the U.S. Department of Veterans Affairs (VA) to Edwards Lifesciences LLC, a for-profit limited liability company that is a subsidiary of Edwards Lifesciences Corporation. The contract is for the delivery of Transcatheter Aortic Valve Replacement (TAVR) products, which are specialized cardiovascular medical devices designed to enhance surgical and cardiovascular care for veterans.

Edwards Lifesciences LLC holds a significant Indefinite Delivery Contract (IDC) with the VA's Veterans Integrated Service Network 19, valued at $1,190,000 with a performance period through December 2029, focused on procuring SAPIEN 3 Transcatheter Heart Valves and other specialized cardiovascular equipment. The company also maintains an active Blanket Purchase Agreement with the VA-VHA, valued at $1,590,000, which allows medical centers within Veterans Integrated Service Network 21 to order various Edwards heart valve models through 2028. These contract vehicles demonstrate Edwards Lifesciences' critical role in providing advanced medical technologies to the veteran healthcare system.

Generated 5/21/25, 9:42 AM